Clinical outcomes and cost-effectiveness of collaborative treatment with Korean and Western medicine in patients with facial palsy: a multicenter prospective observational study

Table 5 GLMM analysis of between-group differences in treatment effectiveness (ITT)

Random effects	HBGS		NRS		EQ-5D-5L		EQ-VAS
Random effects	β	SE	β	SE	β	SE	β	SE
Sex	-0.18	0.13	-0.35	0.18	0.05*	0.02	8.77	2.34
Age	0.01^#	0.00	0.01	0.01	0.00	0.00	0.02	0.08
CT	-0.15	0.17	-0.54^#	0.29	-0.03	0.02	-3.66	3.26
Duration	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.02
Follow up time
2	-1.24*	0.16	-4.79*	0.32	0.02	0.02	7.01*	3.17
3	-1.57*	0.16	-4.97*	0.32	0.07*	0.02	12.19*	3.18
CT x follow-up time
CT x 2	0.07	0.21	0.36	0.39	0.05^#	0.03	8.04*	3.94
CT x 3	-0.23	0.20	0.44	0.39	0.06*	0.03	6.56^#	3.91
constant	3.13*	0.26	5.15*	0.38	0.85*	0.04	57.78*	4.66

β, coefficients; SE, standard error; CT, collaborative treatment; HBGS, House-Brackmann grading scale; NRS, numeric rating scale; EQ-5D-5L, EuroQol-5 dimensions; EQ-VAS, EuroQol-visual analogue scale; GLMM, generalized linear mixed model; ITT, intention-to-treat; * p-value < 0.05; ^# p-value < 0.10

ISSN: 2662-7671